2024 Year in Review — Part 2 episode artwork

EPISODE · Jan 1, 2025 · 12 MIN

2024 Year in Review — Part 2

from Eyewire News: The Podcast · host Eyewire News

In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients with dry AMD; and introduction of novel OCTA technology. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

2024 Year in Review — Part 2

0:00 12:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 12 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on January 1, 2025.

What is this episode about?

In today’s episode, we review the top stories from the second half of 2024. The last six months saw the launch of first-of-its-kind IOLS; the clinical advancement of gene therapies for rare diseases; the FDA approval of a device to treat patients...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!